[go: up one dir, main page]

AU7263600A - Diagnosis, prognosis and treatment of trinucleotide repeat-associated diseases and intranuclear inclusions-associated diseases - Google Patents

Diagnosis, prognosis and treatment of trinucleotide repeat-associated diseases and intranuclear inclusions-associated diseases

Info

Publication number
AU7263600A
AU7263600A AU72636/00A AU7263600A AU7263600A AU 7263600 A AU7263600 A AU 7263600A AU 72636/00 A AU72636/00 A AU 72636/00A AU 7263600 A AU7263600 A AU 7263600A AU 7263600 A AU7263600 A AU 7263600A
Authority
AU
Australia
Prior art keywords
associated diseases
prognosis
diagnosis
treatment
trinucleotide repeat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72636/00A
Inventor
Bernard Brais
Claudia Gaspar
Merdhad Jannatipour
Guy Rouleau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
McGill University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McGill University filed Critical McGill University
Publication of AU7263600A publication Critical patent/AU7263600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
AU72636/00A 1999-09-09 2000-09-08 Diagnosis, prognosis and treatment of trinucleotide repeat-associated diseases and intranuclear inclusions-associated diseases Abandoned AU7263600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15294199P 1999-09-09 1999-09-09
US60152941 1999-09-09
PCT/CA2000/001052 WO2001018544A1 (en) 1999-09-09 2000-09-08 Diagnosis, prognosis and treatment of trinucleotide repeat-associated diseases and intranuclear inclusions-associated diseases

Publications (1)

Publication Number Publication Date
AU7263600A true AU7263600A (en) 2001-04-10

Family

ID=22545102

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72636/00A Abandoned AU7263600A (en) 1999-09-09 2000-09-08 Diagnosis, prognosis and treatment of trinucleotide repeat-associated diseases and intranuclear inclusions-associated diseases

Country Status (4)

Country Link
EP (1) EP1214597A1 (en)
AU (1) AU7263600A (en)
CA (1) CA2384146A1 (en)
WO (1) WO2001018544A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003020977A2 (en) * 2001-08-31 2003-03-13 The University Court Of The University Of Glasgow Nucleotide repeats assay
WO2006105038A2 (en) * 2005-03-25 2006-10-05 The Uab Research Foundation Methods of altering gene expression and methods of treatment utilizing same
SG11201400125RA (en) * 2011-09-19 2014-03-28 Axon Neuroscience Se Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2764611B1 (en) * 1997-06-11 2002-02-01 Fond Jean Dausset Ceph REPEATED TRIPLET-RICH DNA SEQUENCES USEFUL IN THE DIAGNOSIS OF TRINUCLEOTIDE REPETITIVE DISEASES
CA2218199A1 (en) * 1997-12-09 1999-06-09 Mcgill University Short gcg expansions in the pab ii gene for oculopharyngeal muscular dystrophy and diagnostic thereof
CA2252727A1 (en) * 1998-11-03 2000-05-03 Ridha Joober Polyglutamine containing proteins and use thereof for diagnosis and treatment of cag repeat-linked neuropsychiatric disorders

Also Published As

Publication number Publication date
CA2384146A1 (en) 2001-03-15
EP1214597A1 (en) 2002-06-19
WO2001018544A1 (en) 2001-03-15

Similar Documents

Publication Publication Date Title
AU2001275177A1 (en) Cardiac disease treatment and device
AU2001253565A1 (en) Cardiac disease treatment and device
AU2001275176A1 (en) Cardiac disease treatment and device
AU2001281369A1 (en) Cardiac disease treatment and device
AU2002323258A1 (en) Diagnosis and treatment of vascular disease
GB9903841D0 (en) Diagnosis and treatment of cancer
AU2815900A (en) Clinical and diagnostic database
AU1967501A (en) Device and method for improved diagnosis and treatment of cancer
GB2368794B (en) Prevention and treatment of amyloidogenic disease
AU2002255248A1 (en) Diagnosis, treatment and research of mental disorders
AU5788300A (en) Medical treatment method and kit
AU2002367535A1 (en) Diagnosis and treatment of vascular disease
HUP0201205A2 (en) Prevention and treatment of amyloidogenic disease
AUPP784398A0 (en) Kidney disease detection and treatment
AU8026200A (en) Treatment of heart disease with cox-2 inhibitors
AU6425800A (en) Agents for the diagnosis, prognosis and treatment of malignant diseases
AU2002326813A1 (en) Diagnosis and treatment of vascular disease
AU2002341880A1 (en) Diagnosis and treatment of vascular disease
AU2003210266A1 (en) Treatment, diagnosis and imaging of disease
AU1238501A (en) Process for consumer-directed diagnostic and health care information
AU4654500A (en) Prevention, diagnosis and treatment of lyme disease
AU2002341604A1 (en) Diagnosis and treatment of vascular disease
GB9909392D0 (en) Treatment, imaging and diagnosis of disease
AU7263600A (en) Diagnosis, prognosis and treatment of trinucleotide repeat-associated diseases and intranuclear inclusions-associated diseases
AU2002330724A1 (en) Diagnosis, prevention and treatment of cancer

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase